163 related articles for article (PubMed ID: 32355909)
1. Prioritizing outcome preferences in patients with ocular hypertension and open-angle glaucoma using best-worst scaling.
Le JT; Bicket AK; Janssen EM; Grover D; Radhakrishnan S; Vold S; Tarver ME; Eydelman M; Bridges JFP; Li T
Ophthalmol Glaucoma; 2019; 2(6):367-373. PubMed ID: 32355909
[TBL] [Abstract][Full Text] [Related]
2. Identifying outcomes that are important to patients with ocular hypertension or primary open-angle glaucoma: a qualitative interview study.
Le JT; Mohanty K; Bicket AK; Tarver ME; Eydelman M; Li T
Ophthalmol Glaucoma; 2019; 2(6):374-382. PubMed ID: 32455341
[TBL] [Abstract][Full Text] [Related]
3. Priorities and Treatment Preferences among Surgery-Naive Patients with Moderate to Severe Open-Angle Glaucoma.
Bicket AK; Le JT; Yorkgitis C; Li T
Ophthalmol Glaucoma; 2020; 3(5):377-383. PubMed ID: 32768363
[TBL] [Abstract][Full Text] [Related]
4. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
King AJ; Rotchford AP
JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.
Wang K; Xu L; Yuan Z; Yao K; Zhao J; Xu L; Fang A; Zhang M; Wu L; Ji J; Hou J; Liu Q; Sun X
BMC Ophthalmol; 2014 Feb; 14():21. PubMed ID: 24568617
[TBL] [Abstract][Full Text] [Related]
6. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
7. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
Diestelhorst M
Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475
[TBL] [Abstract][Full Text] [Related]
8. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial.
Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G;
Ophthalmology; 2019 Sep; 126(9):1238-1248. PubMed ID: 31028768
[TBL] [Abstract][Full Text] [Related]
9. Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2.
Asrani S; Bacharach J; Holland E; McKee H; Sheng H; Lewis RA; Kopczynski CC; Heah T
Adv Ther; 2020 Apr; 37(4):1620-1631. PubMed ID: 32166538
[TBL] [Abstract][Full Text] [Related]
10. The Effectiveness and Safety of Micropulse Cyclophotocoagulation in the Treatment of Ocular Hypertension and Glaucoma.
Kaba Q; Somani S; Tam E; Yuen D
Ophthalmol Glaucoma; 2020; 3(3):181-189. PubMed ID: 32672613
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.
Chen YY; Wang TH; Liu C; Wu KY; Chiu SL; Simonyi S; Lu DW
BMC Ophthalmol; 2016 Sep; 16(1):162. PubMed ID: 27633513
[TBL] [Abstract][Full Text] [Related]
12. Intraocular Pressure in the Eyes of Patients With Carotid-Cavernous Fistulas: Profile, Intereye Asymmetry, and Treatment Outcomes.
Khurana M; Alam MS; Balekudaru S; Vijaya L; Madhuri MB; Halbe SV; Noronha VO; George RJ; Mukherjee B
J Glaucoma; 2019 Dec; 28(12):1074-1078. PubMed ID: 31658226
[TBL] [Abstract][Full Text] [Related]
13. Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study.
Aihara M; Ropo A; Lu F; Kawata H; Iwata A; Odani-Kawabata N; Shams N
Jpn J Ophthalmol; 2020 Jul; 64(4):398-406. PubMed ID: 32572719
[TBL] [Abstract][Full Text] [Related]
14. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis.
Li F; Huang W; Zhang X
Acta Ophthalmol; 2018 May; 96(3):e277-e284. PubMed ID: 29144028
[TBL] [Abstract][Full Text] [Related]
16. A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension.
Natt NK; Gupta A; Singh G; Singh T
Indian J Ophthalmol; 2014 Dec; 62(12):1136-40. PubMed ID: 25579357
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
Realini TD
Ophthalmology; 2009 Jul; 116(7):1237-42. PubMed ID: 19576495
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of locally produced Latanoprost in the control of intraocular pressure in patients with primary open-angle glaucoma.
Mahar PS; Butt NH; Ali SI
Int Ophthalmol; 2018 Dec; 38(6):2593-2597. PubMed ID: 29209880
[TBL] [Abstract][Full Text] [Related]
19. Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension.
Opitz DL; Tung S; Jang US; Park JJ
Clin Exp Optom; 2011 Sep; 94(5):438-42. PubMed ID: 21342261
[TBL] [Abstract][Full Text] [Related]
20. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
Simmons ST; Earl ML;
Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
